Clinical Trial Update: Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib [Phase 4]

View source ↗

Summary

Phase 4 study evaluating persistence of the immune response to hepatitis B in 4-6 year-old children previously vaccinated with the hexavalent DTPa-HBV-IPV/Hib v…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• DTPa-HBV-IPV/Hib (Diphtheria and tetanus toxoids and acellular pertussis vaccine; Hepatitis B vaccine; Inactivated poliovirus vaccine; Haemophilus influenzae type b conjugate vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 4 | Status: COMPLETED